Aigen Investment Management, LP Atri Cure, Inc. Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$32.99 - $43.25 $45,625 - $59,814	1,383 Added 24.04%	7,136 $254,000
Q3 2023 Nov 13, 2023	SELL	$41.12 - $57.73 $22,492 - $31,578	-547 Reduced 8.68%	5,753 $251,000
Q2 2023 Aug 14, 2023	SELL	$40.44 - $49.6 $297,031 - $364,312	-7,345 Reduced 53.83%	6,300 $310,000
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $489,446 - $644,316	13,645 New	13,645 $565,000
Q2 2020 Aug 10, 2020	SELL	$31.78 - $51.19 $12,616 - $20,322	-397 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$24.49 - $43.84 $9,722 - $17,404	397 New	397 $13,000

212

49.6M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.85B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.